The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease - Wikidata - wikimedia - TriplyDB

The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease

The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease

http://www.wikidata.org/entity/Q27015129

about

1,4-Dihydropyridine Derivatives: Dihydronicotinamide Analogues-Model Compounds Targeting Oxidative Stress Edaravone promotes functional recovery after mechanical peripheral nerve injury Effect of edaravone on favorable outcome in patients with acute cerebral large vessel occlusion: subanalysis of RESCUE-Japan Registry.Edaravone mitigates hexavalent chromium-induced oxidative stress and depletion of antioxidant enzymes while estrogen restores antioxidant enzymes in the rat ovary in F1 offspring.Targeting metabolic disorders by natural products.Analysis of treatment effect of urinary kallidinogenase combined with edaravone on massive cerebral infarction.Potential application of in vivo imaging of impaired lymphatic duct to evaluate the severity of pressure ulcer in mouse model Is Edaravone the Future of Free Radical Scavenging in Inflammatory States?Mitochondria-Targeted Antioxidants for the Treatment of Cardiovascular Disorders.Edaravone protects against cobalt chloride-induced dysfunctions in apoptosis and invasion in trophoblast cells.Edaravone protects osteoblastic cells from dexamethasone through inhibiting oxidative stress and mPTP opening.Protective Effect of Edaravone Against Cyclosporine-Induced Chronic Nephropathy Through Antioxidant and Nitric Oxide Modulating Pathways in Rats.Advanced glycation end products induce endothelial-to-mesenchymal transition via downregulating Sirt 1 and upregulating TGF-β in human endothelial cells.Effect of edaravone in diabetes mellitus-induced nephropathy in rats.Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor.Edaravone ameliorates the adverse effects of valproic acid toxicity in small intestine.Edaravone, a Synthetic Free Radical Scavenger, Enhances Alteplase-Mediated Thrombolysis.Antioxidant treatment ameliorates diabetes-induced dysfunction of the vas deferens in a rat model.Edaravone injection ameliorates cognitive deficits in rat model of Alzheimer's disease.Insights on Localized and Systemic Delivery of Redox-Based Therapeutics.Edaravone protects rats against oxidative stress and apoptosis in experimentally induced myocardial infarction: Biochemical and ultrastructural evidence.Edaravone Improves Septic Cardiac Function by Inducing an HIF-1α/HO-1 Pathway.

P2860

Q26765819-D2283AB5-ABF5-49E6-ACAF-6217C478A016 Q34412765-BFD5892C-AB71-401C-9674-0318EDA9CEFF Q34465685-CE6961AE-31A4-482D-BBC5-10AF1401D027 Q35617219-195CC9A9-7E1E-4AC3-8B31-55E35BA3E6F0 Q35830892-0ACFE0FC-0A2F-4B82-A0BB-79CD24E45C8B Q37108311-26D76F8D-7520-4145-9A41-06078B6D44A4 Q37601595-A2068389-5FB5-4356-A73A-5D142D1D190E Q38642480-6EF8DD15-D6A1-4191-9D9A-6382D5A8283D Q38678059-7074237D-BF7F-49D3-A2EC-B8FA57952893 Q38774540-D387334F-A5D1-4D2F-B8D2-483E9DFA4979 Q38852430-68A645A4-DD0E-451E-922B-66799E06A33C Q38866113-5493957A-D5D6-4C5D-A1B7-0C4328623FA8 Q42180745-3D25867D-3AE4-4AAC-B9E5-891E1EE86A17 Q42434867-023EC220-34D6-435A-9C2F-0512A962D04A Q42776028-358E3D72-B50C-4930-A837-63C2D90ECCCB Q46826907-DF296BA9-6BDD-48AC-A93B-8A1791751717 Q47137226-476A4D7E-05F4-455C-9D86-4C560CAC1870 Q48209312-D38E5DFF-39CA-4BA2-BFCF-6395981C4E9C Q50578510-F9B7F17A-8DE9-4B63-82A7-48A029A17C26 Q52720174-C971FA33-8B4D-44CF-8469-DEFE51A6F422 Q53536668-44B86F62-6C1E-46DB-8C3B-034EB80DC87E Q55128459-25E768A4-6F0A-481F-8CD6-352DE1AD1F34

P2860

The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease

http://www.wikidata.org/entity/Q27015129

description

2013 nî lūn-bûn

@nan

2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease

@ast

The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease

@en

The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease

@nl

type

label

The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease

@ast

The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease

@en

The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease

@nl

prefLabel

The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease

@ast

The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease

@en

The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease

@nl

P1433

Q27015129-C1C2A1EA-90D3-490B-8ABF-B19BFC0175A0

P1476

Q27015129-1A478977-3F69-4A19-B163-E9B642A3BCCF

P2093

Q27015129-0FA0DD8D-AF92-478E-9C62-EFECC60B08D6

Q27015129-2F6FDD50-6A4C-4EF3-A0B7-669D65300470

Q27015129-5BC0831A-1829-4325-B00A-9CCF18287D30

Q27015129-5F324EC4-421D-4AF1-88D3-3F85BCE448D5

Q27015129-64762583-201D-41FF-8A8F-420A6ADE5707

Q27015129-BD5650A3-D33E-481E-A64A-742F42E8D47A

P275

Q27015129-27548547-00A9-427E-8C27-F88966C0730A

P2860

Q27015129-032607C1-758C-4751-B12A-F1AF7A6B173E

Q27015129-037125F2-C44C-4776-81A5-FB4B6C7A5A12

Q27015129-082F37E3-EFC3-447E-95F5-D190E7B31DC3

Q27015129-0908A363-D76B-47B0-B7A8-12DD587788F4

Q27015129-0E736B7B-DE98-4FB1-9169-7BB9C06516AB

Q27015129-15FCA75D-7FDF-448A-AB6C-A654E74C22B1

Q27015129-178F870D-8C82-41AF-AF04-1B407EF9332A

Q27015129-1C71F707-55DF-4C09-B10F-782B2779D961

Q27015129-1CC56CCF-F73A-478F-8C69-B2FFF8912C48

Q27015129-1E6F5242-9196-48C0-A6E4-CB8B901ACC8B

P304

Q27015129-3D47A6A2-ED7B-4B08-B92B-8F36F46624DF

P31

Q27015129-7C7B71EF-17C2-41E1-BE17-ADB7E2864DF5

P3181

Q27015129-53042F8C-4EB2-4AB6-ACD5-4AD62D3F44ED

P356

Q27015129-C167A711-81B4-4894-9E09-C779EC0DF062

P407

Q27015129-04D1F62A-F05E-492F-BCB6-B983F5BDF3C0

P433

Q27015129-02480B18-BD55-4854-B099-74A588E84F7F

P478

Q27015129-6E7BFDB2-D95F-4E4F-94FB-4D615EBB6461

P50

Q27015129-EFB86C3B-DA51-41F2-AD5A-C2442C904B44

P577

Q27015129-917E983E-D615-41F3-BB43-42BDC4FA23C3

P5875

Q27015129-D146CC10-36F8-425A-8EE1-E4167767016F

P698

Q27015129-C6DCD74B-162D-4369-9EAA-0E925820BE09

P921

Q27015129-33CE87F1-9E5A-434D-AC85-CEED5D57F5C3

Q27015129-5D5870E1-FD88-463A-BDD3-58395AB45C44

Q27015129-6F0848BC-A5C3-4FEC-A757-57DFA2FDDE53

Q27015129-B9DE2741-0D26-46A8-9AB0-BA2910AA6E4D

P932

Q27015129-4C707682-222D-4CD3-BCF9-8AE999EFB365

P3181

P356

P1433

International Journal of Molecular Sciences

P1476

The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease

@en

P2093

Eiichiro Tanaka

http://www.w3.org/2001/XMLSchema#string

Kiyoshi Kikuchi

http://www.w3.org/2001/XMLSchema#string

Motohiro Morioka

http://www.w3.org/2001/XMLSchema#string

Munetake Yoshitomi

http://www.w3.org/2001/XMLSchema#string

Nobuyuki Takeshige

http://www.w3.org/2001/XMLSchema#string

Yoshinaka Murai

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials

Atherosclerosis — An Inflammatory Disease

Enhanced TNF alpha and oxidative stress in patients with heart failure: effect of TNF alpha on platelet O2- production

The antioxidant nutrients and disease prevention--what do we know and what do we need to find out?

Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers

Cellular defense against H2O2-induced apoptosis via MAP kinase-MKP-1 pathway

1,026 experimental treatments in acute stroke

NAD(P)H oxidase: role in cardiovascular biology and disease

Inflammation, atherosclerosis, and stroke.

P304

13909-13930

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

538606

http://www.w3.org/2001/XMLSchema#string

P356

10.3390/IJMS140713909

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Salunya Tancharoen

P577

2013-07-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

251569205

http://www.w3.org/2001/XMLSchema#string

P698

23880849

http://www.w3.org/2001/XMLSchema#string

P921

heterocyclic compound

mechanism of action

cardiovascular disease

P932

3742225

http://www.w3.org/2001/XMLSchema#string